STOCK TITAN
  1. Home
  2. Sec-filings
  3. SLN
  4. [Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity

[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock SLN logo
Silence Therapeutics Plc

NASDAQ:SLN

SLN Rankings

#4110 Ranked by Market Cap
N/A Ranked by Dividends

SLN Latest News

Sep 2, 2025
Silence Therapeutics to Participate in September Investor Conferences
Aug 7, 2025
Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Jun 12, 2025
Silence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia Vera
May 8, 2025
Silence Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 6, 2025
Silence Therapeutics Welcomes Tim McInerney to Board of Directors

SLN Latest SEC Filings

Aug 14, 2025
[8-K] Silence Therapeutics Plc American Depository Share Reports Material Event
Aug 7, 2025
[10-Q] Silence Therapeutics Plc American Depository Share Quarterly Earnings Report
Aug 7, 2025
[8-K] Silence Therapeutics Plc American Depository Share Reports Material Event
Aug 4, 2025
[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity
Jul 31, 2025
[Form 4] Silence Therapeutics Plc American Depository Share Insider Trading Activity

SLN Stock Data

245.62M
34.75M
24.38%
44.31%
1.61%
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
LONDON